Madeleine G. Moule

The paper develops a peptide-based therapy that targets intracellular Pseudomonas aeruginosa and synergizes with obsolete antibiotics to reduce bacterial reservoirs.

This study demonstrates that the peptide-mimetic TM5 effectively kills Pseudomonas aeruginosa in vitro and reduces bacterial load in a mouse model of infection with low toxicity.